For Davenport residents, the nearest obesity specialist may be a long drive away. Zepbound® is the FDA-approved Injectable pen Tirzepatide product by Eli Lilly, approved since 2023 for Chronic weight management. Weight Method offers a separate program: licensed Iowa providers evaluate eligible patients via telehealth and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program starts at $329/month, including the provider evaluation, the medication, ongoing care, and shipping to Davenport.
FDA-approved Zepbound prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Davenport is already seeing results
Zepbound in Davenport, IA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Zepbound to patients in Davenport from $329/month with virtual consultations and direct-to-door shipping.
Tirzepatide targets the biological mechanisms involved in sustained weight regulation. By activating GLP-1 receptors in the brain, it can reduce hunger signals and slow gastric emptying. Eli Lilly developed Zepbound® as the FDA-approved Injectable pen product, taken Once weekly, approved in 2023. Weight Method is a separate program: licensed providers in Iowa evaluate eligible patients via telehealth and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program for eligible Davenport, IA residents starts at $329/month.
City life in Davenport brings convenience in many forms, but it also brings sedentary desk jobs, food delivery temptation, and stress-driven eating patterns that make weight management difficult. Tirzepatide therapy works at the biological level — reducing hunger and cravings — so Davenport residents can make better choices even during their busiest days. Weight Method prescribes compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy, at $329/month through virtual consultations that fit into a lunch break. Compounded Tirzepatide is not FDA-approved.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Iowa and start Zepbound from $329/month.
Get Started NowFree consultation. No commitment.